Literature DB >> 28206697

Heparanase 1 involvement in prostate physiopathology.

Guilherme O Barbosa1, Nilva K Cervigne2, Hernandes F Carvalho1, Taize M Augusto2.   

Abstract

The prostate is a compound exocrine gland of the male reproductive tract universally present in mammals. It is highly responsive to androgen and can be committed by a variety of pathological complications as prostatitis, benign, and malignant proliferative changes, which may be intensified by aging. Prostate intensively turnover its extracellular matrix (ECM) either at homeostasis or disease which includes a dynamically change of glycosaminoglycan composition during the life of an individual. Among the different enzymes playing a role in such changes, heparanase-1 is responsible for cleaving heparan sulfate (HS) at a limited number of sites, clearly involved in tissue remodeling. Its activity has been strongly implicated in cell invasion associated with cancer metastasis, a consequence of the structural modification that loosens the ECM barrier. In the present review we focuses in some aspects of the prostate physiology and diseases, particular prostate cancer, evidencing how the HPSE-1 activity encompasses the relationship of both processes.
© 2017 International Federation for Cell Biology.

Entities:  

Keywords:  cancer; heparanase 1; physiology; prostate gland

Mesh:

Substances:

Year:  2017        PMID: 28206697     DOI: 10.1002/cbin.10748

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  3 in total

1.  Heparanase-1 is downregulated in chemoradiotherapy orbital rhabdomyosarcoma and relates with tumor growth as well as angiogenesis.

Authors:  Wei-Qiang Tang; Yan Hei; Jing Lin
Journal:  Int J Ophthalmol       Date:  2022-01-18       Impact factor: 1.779

Review 2.  Markers of Toxicity and Response to Radiation Therapy in Patients With Prostate Cancer.

Authors:  Nicola J Nasser; Jonathan Klein; Abed Agbarya
Journal:  Adv Radiat Oncol       Date:  2020-10-27

3.  Heparanase regulates EMT and cancer stem cell properties in prostate tumors.

Authors:  Valentina Masola; Marco Franchi; Gianluigi Zaza; Francesca Mansa Atsina; Giovanni Gambaro; Maurizio Onisto
Journal:  Front Oncol       Date:  2022-07-27       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.